Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Exited in 2025. Management misallocated Covid...
— Stephen Dodson and Raphael de Balmann
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Revvity Inc.
Revvity ($RVTY) is a specialized life science tools and diagnostic testing company providing research informatics software, preclinical discovery reagents, and clinical diagnostic systems. Madison initiated a...
Shares declined due to negative sentiment surrounding conservative government and academic research funding. However, the company...
Revvity successfully restructured post-pandemic by divesting lower-margin assets to build specialized diagnostic and research reagent franchises. The company trades...
More institutional theses from Bretton Fund
The manager argues that fears of AI disrupting payment card networks are overblown. Card networks possess...
Mastercard acts as a vital digital infrastructure player whose network effects protect it from emerging technologies. Concerns about AI...
The card networks function as essential digital infrastructure, processing high volumes of transactions with deep merchant and consumer trust. While AI-to-AI or...